Selected research
Market Outlook & Growth Opportunities
Global Automated and Rapid Microbiological Tests Bussiness Market Outlook and Growth Opportunities 2026
Market perspective
The global Automated and Rapid Microbiological Tests Bussiness market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automated and Rapid Microbiological Tests Bussiness is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Automated and Rapid Microbiological Tests Bussiness market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Automated and Rapid Microbiological Tests Bussiness market include Thermo Fisher Scientific, Roche, Siemens Healthcare Diagnostics, Sekisui Diagnostics, Remel, Quidel Corporation, Oxoid Limited, Orion Diagnostica Oy and Orasure Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Automated and Rapid Microbiological Tests Bussiness market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Automated and Rapid Microbiological Tests Bussiness and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Automated and Rapid Microbiological Tests Bussiness revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Automated and Rapid Microbiological Tests Bussiness market.
Automated and Rapid Microbiological Tests Bussiness Segment by Company
Thermo Fisher Scientific
Roche
Siemens Healthcare Diagnostics
Sekisui Diagnostics
Remel
Quidel Corporation
Oxoid Limited
Orion Diagnostica Oy
Orasure Technologies
Meridian Biosciences
MedMira
Gen-Probe
Celsis International
Cellabs
Bio-Rad Laboratories
BioMerieux SA
Becton Dickinson and Company
Abbott Laboratories
Automated and Rapid Microbiological Tests Bussiness Segment by Type
Automated Identification & Susceptibility Systems
Automated Tuberculosis Systems
Automated Blood Culture Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other
Automated and Rapid Microbiological Tests Bussiness Segment by Application
Clinical
Non-Clinical
Automated and Rapid Microbiological Tests Bussiness Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Automated and Rapid Microbiological Tests Bussiness status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Automated and Rapid Microbiological Tests Bussiness key companies, revenue, market share, and recent developments.
3. To split the Automated and Rapid Microbiological Tests Bussiness breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Automated and Rapid Microbiological Tests Bussiness market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Automated and Rapid Microbiological Tests Bussiness significant trends, drivers, influence factors in global and regions.
6. To analyze Automated and Rapid Microbiological Tests Bussiness competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated and Rapid Microbiological Tests Bussiness market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated and Rapid Microbiological Tests Bussiness and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated and Rapid Microbiological Tests Bussiness.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automated and Rapid Microbiological Tests Bussiness industry.
Chapter 3: Detailed analysis of Automated and Rapid Microbiological Tests Bussiness company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Automated and Rapid Microbiological Tests Bussiness in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Automated and Rapid Microbiological Tests Bussiness in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Identification & Susceptibility Systems
- Automated Tuberculosis Systems
- Automated Blood Culture Systems
- Streptococcal Infection Rapid Tests
- GC/Chlamydia Rapid Tests
- Other
Applications
- Clinical
- Non-Clinical
Companies covered
- Thermo Fisher Scientific
- Roche
- Siemens Healthcare Diagnostics
- Sekisui Diagnostics
- Remel
- Quidel Corporation
- Oxoid Limited
- Orion Diagnostica Oy
- Orasure Technologies
- Meridian Biosciences
- MedMira
- Gen-Probe
- Celsis International
- Cellabs
- Bio-Rad Laboratories
- BioMerieux SA
- Becton Dickinson and Company
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Automated and Rapid Microbiological Tests Bussiness Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Automated and Rapid Microbiological Tests Bussiness Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Automated and Rapid Microbiological Tests Bussiness Market Dynamics
- 2.1 Automated and Rapid Microbiological Tests Bussiness Industry Trends
- 2.2 Automated and Rapid Microbiological Tests Bussiness Industry Drivers
- 2.3 Automated and Rapid Microbiological Tests Bussiness Industry Opportunities and Challenges
- 2.4 Automated and Rapid Microbiological Tests Bussiness Industry Restraints
3 Automated and Rapid Microbiological Tests Bussiness Market by Company
- 3.1 Global Automated and Rapid Microbiological Tests Bussiness Company Revenue Ranking in 2025
- 3.2 Global Automated and Rapid Microbiological Tests Bussiness Revenue by Company (2021-2026)
- 3.3 Global Automated and Rapid Microbiological Tests Bussiness Company Ranking (2024-2026)
- 3.4 Global Automated and Rapid Microbiological Tests Bussiness Company Manufacturing Base and Headquarters
- 3.5 Global Automated and Rapid Microbiological Tests Bussiness Company Product Type and Application
- 3.6 Global Automated and Rapid Microbiological Tests Bussiness Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Automated and Rapid Microbiological Tests Bussiness Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Automated and Rapid Microbiological Tests Bussiness Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Automated and Rapid Microbiological Tests Bussiness Market by Type
- 4.1 Automated and Rapid Microbiological Tests Bussiness Type Introduction
- 4.1.1 Automated Identification & Susceptibility Systems
- 4.1.2 Automated Tuberculosis Systems
- 4.1.3 Automated Blood Culture Systems
- 4.1.4 Streptococcal Infection Rapid Tests
- 4.1.5 GC/Chlamydia Rapid Tests
- 4.1.6 Other
- 4.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type
- 4.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Type (2021-2032)
- 4.2.3 Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type (2021-2032)
5 Automated and Rapid Microbiological Tests Bussiness Market by Application
- 5.1 Automated and Rapid Microbiological Tests Bussiness Application Introduction
- 5.1.1 Clinical
- 5.1.2 Non-Clinical
- 5.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application
- 5.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Application (2021-2032)
- 5.2.3 Global Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application (2021-2032)
6 Automated and Rapid Microbiological Tests Bussiness Regional Value Analysis
- 6.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region (2021-2032)
- 6.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region: 2021-2026
- 6.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
- 6.3.2 North America Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
- 6.4.2 Europe Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
- 6.6.2 South America Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Country, 2025 VS 2032
7 Automated and Rapid Microbiological Tests Bussiness Country-level Value Analysis
- 7.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2021-2032)
- 7.2.1 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2021-2026)
- 7.2.2 Global Automated and Rapid Microbiological Tests Bussiness Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.7.2 France Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.14.2 China Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.17.2 India Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Automated and Rapid Microbiological Tests Bussiness Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific
- 8.1.1 Thermo Fisher Scientific Company Information
- 8.1.2 Thermo Fisher Scientific Business Overview
- 8.1.3 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.1.5 Thermo Fisher Scientific Recent Developments
- 8.2 Roche
- 8.2.1 Roche Company Information
- 8.2.2 Roche Business Overview
- 8.2.3 Roche Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.2.4 Roche Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.2.5 Roche Recent Developments
- 8.3 Siemens Healthcare Diagnostics
- 8.3.1 Siemens Healthcare Diagnostics Company Information
- 8.3.2 Siemens Healthcare Diagnostics Business Overview
- 8.3.3 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.3.4 Siemens Healthcare Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.3.5 Siemens Healthcare Diagnostics Recent Developments
- 8.4 Sekisui Diagnostics
- 8.4.1 Sekisui Diagnostics Company Information
- 8.4.2 Sekisui Diagnostics Business Overview
- 8.4.3 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.4.4 Sekisui Diagnostics Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.4.5 Sekisui Diagnostics Recent Developments
- 8.5 Remel
- 8.5.1 Remel Company Information
- 8.5.2 Remel Business Overview
- 8.5.3 Remel Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.5.4 Remel Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.5.5 Remel Recent Developments
- 8.6 Quidel Corporation
- 8.6.1 Quidel Corporation Company Information
- 8.6.2 Quidel Corporation Business Overview
- 8.6.3 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.6.4 Quidel Corporation Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.6.5 Quidel Corporation Recent Developments
- 8.7 Oxoid Limited
- 8.7.1 Oxoid Limited Company Information
- 8.7.2 Oxoid Limited Business Overview
- 8.7.3 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.7.4 Oxoid Limited Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.7.5 Oxoid Limited Recent Developments
- 8.8 Orion Diagnostica Oy
- 8.8.1 Orion Diagnostica Oy Company Information
- 8.8.2 Orion Diagnostica Oy Business Overview
- 8.8.3 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.8.4 Orion Diagnostica Oy Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.8.5 Orion Diagnostica Oy Recent Developments
- 8.9 Orasure Technologies
- 8.9.1 Orasure Technologies Company Information
- 8.9.2 Orasure Technologies Business Overview
- 8.9.3 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.9.4 Orasure Technologies Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.9.5 Orasure Technologies Recent Developments
- 8.10 Meridian Biosciences
- 8.10.1 Meridian Biosciences Company Information
- 8.10.2 Meridian Biosciences Business Overview
- 8.10.3 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.10.4 Meridian Biosciences Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.10.5 Meridian Biosciences Recent Developments
- 8.11 MedMira
- 8.11.1 MedMira Company Information
- 8.11.2 MedMira Business Overview
- 8.11.3 MedMira Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.11.4 MedMira Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.11.5 MedMira Recent Developments
- 8.12 Gen-Probe
- 8.12.1 Gen-Probe Company Information
- 8.12.2 Gen-Probe Business Overview
- 8.12.3 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.12.4 Gen-Probe Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.12.5 Gen-Probe Recent Developments
- 8.13 Celsis International
- 8.13.1 Celsis International Company Information
- 8.13.2 Celsis International Business Overview
- 8.13.3 Celsis International Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.13.4 Celsis International Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.13.5 Celsis International Recent Developments
- 8.14 Cellabs
- 8.14.1 Cellabs Company Information
- 8.14.2 Cellabs Business Overview
- 8.14.3 Cellabs Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.14.4 Cellabs Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.14.5 Cellabs Recent Developments
- 8.15 Bio-Rad Laboratories
- 8.15.1 Bio-Rad Laboratories Company Information
- 8.15.2 Bio-Rad Laboratories Business Overview
- 8.15.3 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.15.4 Bio-Rad Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.15.5 Bio-Rad Laboratories Recent Developments
- 8.16 BioMerieux SA
- 8.16.1 BioMerieux SA Company Information
- 8.16.2 BioMerieux SA Business Overview
- 8.16.3 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.16.4 BioMerieux SA Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.16.5 BioMerieux SA Recent Developments
- 8.17 Becton Dickinson and Company
- 8.17.1 Becton Dickinson and Company Company Information
- 8.17.2 Becton Dickinson and Company Business Overview
- 8.17.3 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.17.4 Becton Dickinson and Company Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.17.5 Becton Dickinson and Company Recent Developments
- 8.18 Abbott Laboratories
- 8.18.1 Abbott Laboratories Company Information
- 8.18.2 Abbott Laboratories Business Overview
- 8.18.3 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Revenue and Gross Margin (2021-2026)
- 8.18.4 Abbott Laboratories Automated and Rapid Microbiological Tests Bussiness Product Portfolio
- 8.18.5 Abbott Laboratories Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst